SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/08/19 Biolase, Inc 10-K 12/31/18 86:14M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.28M 2: EX-10.28 Material Contract HTML 93K 3: EX-21.1 Subsidiaries List HTML 22K 4: EX-23.1 Consent of Experts or Counsel HTML 26K 5: EX-31.1 Certification -- §302 - SOA'02 HTML 32K 6: EX-31.2 Certification -- §302 - SOA'02 HTML 32K 7: EX-32.1 Certification -- §906 - SOA'02 HTML 26K 8: EX-32.2 Certification -- §906 - SOA'02 HTML 26K 15: R1 Document and Entity Information HTML 60K 16: R2 Consolidated Balance Sheets HTML 109K 17: R3 Consolidated Balance Sheets (Parenthetical) HTML 46K 18: R4 Consolidated Statements Of Operations And HTML 108K Comprehensive Loss 19: R5 Consolidated Statements Of Shareholders' Equity HTML 95K 20: R6 Consolidated Statements Of Shareholders' Equity HTML 26K (Parenthetical) 21: R7 Consolidated Statements Of Cash Flows HTML 141K 22: R8 Basis of Presentation HTML 43K 23: R9 Summary of Significant Accounting Policies HTML 277K 24: R10 Supplementary Balance Sheet Information HTML 138K 25: R11 Intangible Assets and Goodwill HTML 66K 26: R12 Income Taxes HTML 226K 27: R13 Debt HTML 91K 28: R14 Commitments and Contingencies HTML 47K 29: R15 Stockholders' Equity HTML 418K 30: R16 Segment Information HTML 49K 31: R17 Concentrations HTML 89K 32: R18 Subsequent Events (Unaudited) HTML 31K 33: R19 Schedule II-Consolidated Valuation and Qualifying HTML 118K Accounts and Reserves 34: R20 Summary of Significant Accounting Policies HTML 367K (Policies) 35: R21 Summary of Significant Accounting Policies HTML 242K (Tables) 36: R22 Supplementary Balance Sheet Information (Tables) HTML 144K 37: R23 Intangible Assets and Goodwill (Tables) HTML 64K 38: R24 Income Taxes (Tables) HTML 224K 39: R25 Debt (Tables) HTML 78K 40: R26 Commitments and Contingencies (Tables) HTML 36K 41: R27 Stockholders' Equity (Tables) HTML 353K 42: R28 Segment Information (Tables) HTML 47K 43: R29 Concentrations (Tables) HTML 89K 44: R30 Basis of Presentation - Additional Information HTML 68K (Detail) 45: R31 Summary of Significant Accounting Policies - HTML 100K Additional Information (Detail) 46: R32 Schedule of Reconciliation of Cash, Cash HTML 36K Equivalents, and Restricted Cash (Detail) 47: R33 Estimated Useful Lives of Property, Plant and HTML 38K Equipment (Detail) 48: R34 Summary of Opening and Closing Balances of HTML 40K Contract Liabilities (Detail) 49: R35 Summary of Disaggregation of Revenues Related to HTML 32K Geographic Areas (Detail) 50: R36 Summary of Revenues Disaggregated by Timing of HTML 33K Goods and Services Transferred (Detail) 51: R37 Summary of Sales by End Market (Detail) HTML 33K 52: R38 Changes in Initial Product Warranty Accrual and HTML 40K Expenses Under Initial and Extended Warranties (Detail) 53: R39 Classification of Compensation Expense Associated HTML 38K with Share-Based Payments (Detail) 54: R40 Assumptions Used in Estimating Fair Value of Stock HTML 33K Options Granted (Detail) 55: R41 Components of Accounts Receivable, Net of HTML 33K Allowance (Detail) 56: R42 Supplementary Balance Sheet Information - HTML 42K Additional Information (Detail) 57: R43 Components of Inventory (Detail) HTML 35K 58: R44 Summary of Property, Plant, and Equipment (Detail) HTML 50K 59: R45 Components of Accrued Liabilities (Detail) HTML 49K 60: R46 Intangible Assets and Goodwill - Additional HTML 33K Information (Detail) 61: R47 Intangible Assets and Related Accumulated HTML 52K Amortization (Detail) 62: R48 Summary of Income Tax Current and Deferred HTML 43K Provision (Detail) 63: R49 Federal Income Tax Provision Compared With HTML 55K Statutory Rates (Detail) 64: R50 Summary of Net Deferred Tax Assets and Net HTML 78K Deferred Tax Liabilities (Detail) 65: R51 Income Taxes - Additional Information (Detail) HTML 80K 66: R52 Summary of Unrecognized Tax Benefits (Detail) HTML 31K 67: R53 Debt - Summary of Principal Outstanding and HTML 32K Unamortized Discount (Detail) 68: R54 Debt - Additional Information (Detail) HTML 161K 69: R55 Debt - Summary of Future Minimum Principal HTML 51K Payments (Detail) 70: R56 Commitments and Contingencies - Additional HTML 48K Information (Detail) 71: R57 Future Minimum Rental Commitments Under Lease HTML 35K Agreements (Detail) 72: R58 Stockholders' Equity - Additional Information HTML 810K (Detail) 73: R59 Summary of Warrant Activity (Detail) HTML 54K 74: R60 Summary of Option Activity (Detail) HTML 66K 75: R61 Options Outstanding and Exercisable (Detail) HTML 66K 76: R62 Cash Proceeds Along with Fair Value Disclosures HTML 36K Related to Grants, Exercises, and Vesting Options (Detail) 77: R63 Summary of Unvested Restricted Stock Units HTML 37K (Detail) 78: R64 Segment Information - Additional Information HTML 38K (Detail) 79: R65 Summary of Long-Lived Assets by Geographic HTML 33K Location (Detail) 80: R66 Concentrations - Summary of Net Revenue from HTML 52K Various Products (Detail) 81: R67 Concentrations - Additional Information (Detail) HTML 33K 82: R68 Subsequent Events (unaudited) - Additional HTML 63K Information (Detail) 83: R69 Consolidated Valuation and Qualifying Accounts and HTML 39K Reserves (Detail) 85: XML IDEA XML File -- Filing Summary XML 152K 84: EXCEL IDEA Workbook of Financial Reports XLSX 114K 9: EX-101.INS XBRL Instance -- biol-20181231 XML 4.07M 11: EX-101.CAL XBRL Calculations -- biol-20181231_cal XML 226K 12: EX-101.DEF XBRL Definitions -- biol-20181231_def XML 707K 13: EX-101.LAB XBRL Labels -- biol-20181231_lab XML 1.72M 14: EX-101.PRE XBRL Presentations -- biol-20181231_pre XML 1.23M 10: EX-101.SCH XBRL Schema -- biol-20181231 XSD 257K 86: ZIP XBRL Zipped Folder -- 0001564590-19-006918-xbrl Zip 248K
Exhibit 31.2
CERTIFICATION
I, John R. Beaver, certify that:
1. |
I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2018 of BIOLASE, Inc.; |
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
a. |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
b. |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
c. |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
d. |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. |
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
a. |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
b. |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Date: March 8, 2019 |
By: |
/s/ JOHN R. BEAVER |
|
|
|
|
|
Executive Vice President and Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer) |
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/8/19 | |||
For Period end: | 12/31/18 | SD | ||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/29/22 Biolase, Inc. 424B5 1:399K Donnelley … Solutions/FA 3/31/21 Biolase, Inc. 10-K 12/31/20 88:15M ActiveDisclosure/FA 2/09/21 Biolase, Inc. 424B5 1:495K Donnelley … Solutions/FA 12/08/20 Biolase, Inc. S-1/A 3:585K Donnelley … Solutions/FA |